Skip to main content
Kevin Conlon, MD, Oncology, Bethesda, MD, NIH Clinical Center

KevinConlonMD

Oncology Bethesda, MD

Associate Professor in Medicine, InternalMedicine, Rush University Medical Center

Dr. Conlon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Conlon's full profile

Already have an account?

  • Office

    Building 10 CRC Room 5A22 National Cancer Institute
    National Institute of Health 9000 Rockville Pike Bethesda MD
    Bethesda, MD 20892
    Phone+1 301-402-2913
    Fax+1 301-402-1001
  • Is this information wrong?

Education & Training

  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1983 - 1987
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1983

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1987 - 2024
  • IL State Medical License
    IL State Medical License 1983 - 2014
  • American Board of Internal Medicine Internal Medicine

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • IL-2 and IL-15 Blockade by BNZ-1, an Inhibitor of Selective Γ-chain Cytokines, Decreases Leukemic T-cell Viability  
    Kevin C Conlon, Thomas A Waldmann, Nature

Abstracts/Posters

  • Interleukin-15 (IL-5) in Combination with Avelumab in Relapsed/Refractory Mature T-Cell Malignancies
    Kevin C Conlon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Phase 1 Trial of Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocytic Leukemia
    Kevin C Conlon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

Hospital Affiliations